Related Experiment Video
Updated: Jun 16, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis.
1Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Trogestrasse 30, Munich, Germany. hermann.wagner@mikrobio.med.tum.de
Interferon regulatory factor-8 plays a crucial role in bone metabolism, alongside RANK, RANKL, and osteoprotegrin. This finding expands our understanding of the molecular mechanisms governing bone remodeling.
Area of Science:
- Molecular biology
- Bone metabolism and remodeling
- Immunology
Background:
- Current understanding of bone metabolism focuses on the tumor necrosis factor (TNF) family, specifically RANK, RANKL, and osteoprotegrin (OPG). These molecules are key regulators of osteoclast differentiation and bone resorption.
- RANKL, a member of the TNF superfamily, binds to its receptor RANK on osteoclast precursors, initiating their differentiation and activation. OPG acts as a soluble decoy receptor, inhibiting RANKL-RANK interactions and thus suppressing bone resorption.
Discussion:
- The established model of bone metabolism requires revision to include the newly identified role of interferon regulatory factor-8 (IRF8). IRF8 is a transcription factor known for its involvement in immune cell development and function.
- IRF8's function in bone metabolism suggests a potential link between immune regulation and skeletal homeostasis. Its precise molecular interactions within the bone microenvironment are yet to be fully elucidated.
Key Insights:
- Interferon regulatory factor-8 (IRF8) is a critical, previously unrecognized, regulator of bone metabolism.
- The molecular mechanisms of bone remodeling involve a broader network of factors than previously understood, extending beyond the canonical RANK/RANKL/OPG pathway.
- IRF8's involvement highlights potential crosstalk between immune system regulation and skeletal health.
Outlook:
- Further research is needed to elucidate the specific molecular pathways through which IRF8 influences osteoblast and osteoclast activity.
- Investigating IRF8's role may reveal novel therapeutic targets for metabolic bone diseases such as osteoporosis and rheumatoid arthritis.
- Understanding the interplay between IRF8 and the RANK/RANKL/OPG system could lead to more comprehensive treatment strategies for bone disorders.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Osteoclasts in Bone Remodeling
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...